Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Morena

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Blood Purification|May 3, 2008
Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profileMarion Morena, Valérie Gausson, Nadya Mothu, et al.
Free Radical Research|April 5, 2011
Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patientsMarion Morena, Laure Patrier, Isabelle Jaussent, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 25, 2011
Does hemodiafiltration improve the removal of homocysteine?Stéphanie Badiou, Marion Morena, Anne-Sophie Bargnoux, et al.
Journal of Intensive Care Medicine|June 12, 2013
Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortalityKada Klouche, Stephane Pommet, Laurent Amigues, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 20, 2010
Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative statusMarion Morena, Isabelle Jaussent, Lotfi Chalabi, et al.
Mediators of Inflammation|November 8, 2018
sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk PredictionMaëlle Plawecki, Marion Morena, Nils Kuster, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 28, 2021
Evaluation of a new point-of-care testing for creatinine and urea measurementAnne-Sophie Bargnoux, Nils Kuster, Thibault Sutra, et al.
Kidney & Blood Pressure Research|November 27, 2024
Severe Coronary Artery Calcifications in Chronic Kidney Disease Patients, Coupled with Inflammation and Bone Mineral Disease Derangement, Promote Major Adverse Cardiovascular Events through Vascular RemodelingMarion Morena-Carrere, Isabelle Jaussent, Leila Chenine, et al.
Clinical Kidney Journal|July 10, 2024
Beyond sarcopenia: frailty in chronic haemodialysis patientsJean-Sébastien Souweine, Grégoire Pasquier, Marion Morena, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2013
A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patientsAnne-Sophie Bargnoux, Marion Morena, Isabelle Jaussent, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Blood Purification|May 3, 2008
Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profileMarion Morena, Valérie Gausson, Nadya Mothu, et al.
Free Radical Research|April 5, 2011
Reduced glomerular filtration rate, inflammation and HDL cholesterol as main determinants of superoxide production in non-dialysis chronic kidney disease patientsMarion Morena, Laure Patrier, Isabelle Jaussent, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 25, 2011
Does hemodiafiltration improve the removal of homocysteine?Stéphanie Badiou, Marion Morena, Anne-Sophie Bargnoux, et al.
Journal of Intensive Care Medicine|June 12, 2013
Plasma brain natriuretic peptide and troponin levels in severe sepsis and septic shock: relationships with systolic myocardial dysfunction and intensive care unit mortalityKada Klouche, Stephane Pommet, Laurent Amigues, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 20, 2010
Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative statusMarion Morena, Isabelle Jaussent, Lotfi Chalabi, et al.
Mediators of Inflammation|November 8, 2018
sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk PredictionMaëlle Plawecki, Marion Morena, Nils Kuster, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 28, 2021
Evaluation of a new point-of-care testing for creatinine and urea measurementAnne-Sophie Bargnoux, Nils Kuster, Thibault Sutra, et al.
Kidney & Blood Pressure Research|November 27, 2024
Severe Coronary Artery Calcifications in Chronic Kidney Disease Patients, Coupled with Inflammation and Bone Mineral Disease Derangement, Promote Major Adverse Cardiovascular Events through Vascular RemodelingMarion Morena-Carrere, Isabelle Jaussent, Leila Chenine, et al.
Clinical Kidney Journal|July 10, 2024
Beyond sarcopenia: frailty in chronic haemodialysis patientsJean-Sébastien Souweine, Grégoire Pasquier, Marion Morena, et al.
Clinical Chemistry and Laboratory Medicine|February 13, 2013
A combined index of cardiac biomarkers as a risk factor for early cardiovascular mortality in hemodialysis patientsAnne-Sophie Bargnoux, Marion Morena, Isabelle Jaussent, et al.
Pageof 8